ABVC
Price
$2.58
Change
+$0.40 (+18.26%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
43.9M
FULC
Price
$7.10
Change
-$0.28 (-3.79%)
Updated
Jun 27 closing price
Capitalization
383.25M
39 days until earnings call
Interact to see
Advertisement

ABVC vs FULC

Header iconABVC vs FULC Comparison
Open Charts ABVC vs FULCBanner chart's image
ABVC BioPharma
Price$2.58
Change+$0.40 (+18.26%)
Volume$932
Capitalization43.9M
Fulcrum Therapeutics
Price$7.10
Change-$0.28 (-3.79%)
Volume$1.21M
Capitalization383.25M
ABVC vs FULC Comparison Chart in %
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. FULC commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a StrongBuy and FULC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ABVC: $2.59 vs. FULC: $7.10)
Brand notoriety: ABVC and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 273% vs. FULC: 153%
Market capitalization -- ABVC: $43.9M vs. FULC: $383.25M
ABVC [@Biotechnology] is valued at $43.9M. FULC’s [@Biotechnology] market capitalization is $383.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ABVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 4 bullish, 4 bearish.
  • FULC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а +40.49% price change this week, while FULC (@Biotechnology) price change was +1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ABVC is expected to report earnings on Apr 15, 2025.

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($383M) has a higher market cap than ABVC($43.9M). ABVC YTD gains are higher at: 338.136 vs. FULC (51.064). ABVC has higher annual earnings (EBITDA): -2.31M vs. FULC (-8.94M). FULC has more cash in the bank: 227M vs. ABVC (217K). ABVC has less debt than FULC: ABVC (2.17M) vs FULC (8.11M). FULC has higher revenues than ABVC: FULC (80M) vs ABVC (508K).
ABVCFULCABVC / FULC
Capitalization43.9M383M11%
EBITDA-2.31M-8.94M26%
Gain YTD338.13651.064662%
P/E RatioN/AN/A-
Revenue508K80M1%
Total Cash217K227M0%
Total Debt2.17M8.11M27%
FUNDAMENTALS RATINGS
ABVC vs FULC: Fundamental Ratings
ABVC
FULC
OUTLOOK RATING
1..100
1469
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9789
PRICE GROWTH RATING
1..100
3436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is somewhat better than the same rating for ABVC (61). This means that FULC’s stock grew somewhat faster than ABVC’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as ABVC (100). This means that FULC’s stock grew similarly to ABVC’s over the last 12 months.

FULC's SMR Rating (89) in the null industry is in the same range as ABVC (97). This means that FULC’s stock grew similarly to ABVC’s over the last 12 months.

ABVC's Price Growth Rating (34) in the null industry is in the same range as FULC (36). This means that ABVC’s stock grew similarly to FULC’s over the last 12 months.

ABVC's P/E Growth Rating (100) in the null industry is in the same range as FULC (100). This means that ABVC’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCFULC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCVX16.940.03
+0.18%
Thrivent Mid Cap Value S
BAGAX14.30N/A
N/A
Brown Advisory Growth Equity Adv
DHSIX23.64N/A
N/A
Diamond Hill Small Cap I
NRSRX50.86N/A
N/A
Neuberger Berman Sustainable Equity R6
NLSIX19.39N/A
N/A
Neuberger Berman Long Short Instl

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
+18.04%
KNSA - ABVC
40%
Loosely correlated
-1.54%
MRSN - ABVC
33%
Loosely correlated
-10.46%
MLEC - ABVC
31%
Poorly correlated
-7.49%
FULC - ABVC
27%
Poorly correlated
-3.79%
MDXXF - ABVC
25%
Poorly correlated
+7.07%
More